Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...
Vor Biopharma Inc. (NASDAQ:VOR) announced that its board of directors approved a repricing of certain outstanding stock options on Friday. The exercise price for eligible options was reduced to $8.18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback